Form 4: TriSalus Life Sciences: Officer Acquires Shares

Richard Marshak, Chief Commercial Officer of TriSalus Life Sciences, Inc., acquired 561 shares of common stock through the Employee Stock Purchase Plan.

Summary

• Richard Marshak, Chief Commercial Officer of TriSalus Life Sciences, Inc. (TLSI), acquired 561 shares of common stock on June 30, 2026.
• The acquisition was made through the Issuer's Employee Stock Purchase Plan.
• The purchase price was $3.87 per share.
• Following this transaction, Marshak beneficially owns 128,319 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine transaction under an employee stock purchase plan by an executive, rather than a significant strategic event or a large personal investment/divestment.

Positives

• Officer participation in employee stock purchase plan indicates confidence in the company.
• Acquisition of shares by a key executive can be seen as a positive signal to the market.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings, like this one from TriSalus Life Sciences, are standard disclosures for insider transactions. Such filings are closely watched by investors to gauge executive confidence and potential shifts in beneficial ownership.

Stakeholder Impact

• Shareholders: The acquisition by an executive may be interpreted as a positive signal of confidence in the company's future prospects.

Key Dates

Keywords

TriSalus Life Sciences, TLSI, Form 4, Insider Trading, Stock Purchase Plan, Richard Marshak, Chief Commercial Officer, Beneficial Ownership